loader
Find a Test

Factor VIII Antigen

Order Code
086015
CPT
83520
Test Details
Synonyms

FVIII Quantitation (Nonfunctional)

TAT

11 days

Methodology

Enzyme-linked immunosorbent assay (ELISA)

Remarks

Special Instructions:
If the patient's hematocrit exceeds 55%, the volume of citrate in the collection tube must be adjusted. Refer to Coagulation Collection Procedures for directions.

Causes for Rejection
Ideally, the patient should not be on anticoagulant therapy. Avoid warfarin (Coumadin®) therapy for two weeks prior to the test and heparin, direct Xa and thrombin inhibitor therapies for about three days prior to testing.

Performing Location

Accredited Laboratory Partner

Testing Frequency

Contact Technical Support

Test Overview

The test is used for the measurement of the amount of factor VIII protein (not activity) of factor VIII to identify individuals that are cross-reacting material (CRM)-positive.

Specimen Type

Plasma

Volume

1 mL

Specimen Container

Blue stopper 3.2% sodium citrate plasma evacuated tube

Patient Preparation

No special preparation is required for this test. You may eat, drink, and take your medications as normal, unless instructed otherwise by your healthcare provider. Do not draw from an arm with a heparin lock or heparinized catheter.

Collection

Blood should be collected in a blue-top tube containing 3.2% buffered sodium citrate. Evacuated collection tubes must be filled to completion to ensure a proper blood to anticoagulant ratio. The sample should be mixed immediately by gentle inversion at least six times to ensure adequate mixing of the anticoagulant with the blood. A discard tube is not required prior to collection of coagulation samples. When noncitrate tubes are collected for other tests, collect sterile and nonadditive (red-top) tubes prior to citrate (blue-top) tubes. Any tube containing an alternate anticoagulant should be collected after the blue-top tube. Gel-barrier tubes and serum tubes with clot initiators should also be collected after the citrate tubes. Centrifuge and carefully remove the plasma using a plastic transfer pipette, being careful not to disturb the cells. Transfer the plasma into a Labcorp PP transpak frozen purple tube with screw cap (Labcorp No. 49482). Freeze immediately and maintain frozen until tested. To avoid delays in turnaround time when requesting multiple tests on frozen samples, please submit separate frozen specimens for each test requested.

Specimen Stability
Temperature Period
Frozen Contact technical support
Order Code
086015
CPT
83520
Test Details
Synonyms

FVIII Quantitation (Nonfunctional)

TAT

11 days

Methodology

Enzyme-linked immunosorbent assay (ELISA)

Remarks

Special Instructions:
If the patient's hematocrit exceeds 55%, the volume of citrate in the collection tube must be adjusted. Refer to Coagulation Collection Procedures for directions.

Causes for Rejection
Ideally, the patient should not be on anticoagulant therapy. Avoid warfarin (Coumadin®) therapy for two weeks prior to the test and heparin, direct Xa and thrombin inhibitor therapies for about three days prior to testing.

Performing Location

Accredited Laboratory Partner

Testing Frequency

Contact Technical Support

Test Overview

The test is used for the measurement of the amount of factor VIII protein (not activity) of factor VIII to identify individuals that are cross-reacting material (CRM)-positive.

Specimen Type

Plasma

Volume

1 mL

Specimen Container

Blue stopper 3.2% sodium citrate plasma evacuated tube

Patient Preparation

No special preparation is required for this test. You may eat, drink, and take your medications as normal, unless instructed otherwise by your healthcare provider. Do not draw from an arm with a heparin lock or heparinized catheter.

Collection

Blood should be collected in a blue-top tube containing 3.2% buffered sodium citrate. Evacuated collection tubes must be filled to completion to ensure a proper blood to anticoagulant ratio. The sample should be mixed immediately by gentle inversion at least six times to ensure adequate mixing of the anticoagulant with the blood. A discard tube is not required prior to collection of coagulation samples. When noncitrate tubes are collected for other tests, collect sterile and nonadditive (red-top) tubes prior to citrate (blue-top) tubes. Any tube containing an alternate anticoagulant should be collected after the blue-top tube. Gel-barrier tubes and serum tubes with clot initiators should also be collected after the citrate tubes. Centrifuge and carefully remove the plasma using a plastic transfer pipette, being careful not to disturb the cells. Transfer the plasma into a Labcorp PP transpak frozen purple tube with screw cap (Labcorp No. 49482). Freeze immediately and maintain frozen until tested. To avoid delays in turnaround time when requesting multiple tests on frozen samples, please submit separate frozen specimens for each test requested.

Specimen Stability
Temperature Period
Frozen Contact technical support